Salvia miltiorrhiza / TumCI Cancer Research Results

SM, Salvia miltiorrhiza: Click to Expand ⟱

Features:

Salvia miltiorrhiza (Danshen; SM) — a traditional Chinese medicinal root containing two major bioactive classes: lipophilic tanshinones (e.g., tanshinone IIA, cryptotanshinone) and hydrophilic phenolic acids (e.g., salvianolic acid A/B). Studied in oncology, cardiovascular, and neurovascular contexts.

Primary mechanisms (conceptual rank):
1) STAT3 / PI3K-AKT-mTOR suppression (anti-survival signaling; mainly tanshinones)
2) ROS modulation (often ↑ in cancer → apoptosis; ↓ oxidative injury in normal tissue)
3) NF-κB inhibition (anti-inflammatory, anti-proliferative)
4) Cell-cycle arrest (G0/G1 or G2/M; cyclin/CDK modulation)
5) Anti-angiogenic signaling (↓ VEGF / HIF-1α coupling)

Bioavailability / PK relevance: Tanshinones are lipophilic with poor oral bioavailability; phenolic acids more water-soluble but rapidly metabolized. Many in-vitro cancer effects occur at concentrations higher than typical plasma levels from oral preparations unless specialized formulations are used.

In-vitro vs oral exposure: Anti-cancer cytotoxicity frequently at micromolar range (qualifier: high concentration only for direct tumor apoptosis).

Clinical evidence status: Widely used in cardiovascular medicine (Asia); oncology evidence largely preclinical or adjunct-hypothesis; no major oncology RCT approval.

Red sage, redroot sage, Chinese sage or danshen.
Salvianolic Acid A (SAA) is predominantly isolated from Salvia miltiorrhiza, commonly known as Danshen.
Tanshinone IIA is the main effective component of Salvia miltiorrhiza known as 'Danshen'

Salvianolic Acid A, primarily derived from Salvia miltiorrhiza (Danshen), shows promise in cancer research due to its ability to inhibit cell proliferation, induce apoptosis, reduce angiogenesis, and impact multiple signaling pathways involved in tumor progression.

Salvianolic Acid A may impact several intracellular signaling pathways involved in cancer progression:
NF-κB Pathway: SAA might inhibit the NF-κB pathway, reducing inflammation and cell proliferation signals.
MAPK Pathways (ERK, JNK, p38): By modulating these pathways, SAA can influence cell survival, differentiation, and apoptosis.
PI3K/Akt Pathway: Inhibition of this pathway is another mechanism through which SAA can reduce cancer cell survival and proliferation.
Oxidative Stress Reduction: SAA’s antioxidant properties may help in reducing oxidative stress, which is implicated in cancer progression and chemoresistance.
Synergistic Effects with Conventional Therapies:
Preliminary studies suggest that Salvianolic Acid A might enhance the effectiveness of various chemotherapeutic agents.

Some studies have observed anti-proliferative effects at concentrations around 10–50 µM. rodent models have been reported in the range of 10–100 mg/kg

Salvia miltiorrhiza (Danshen) — Cancer vs Normal Cell Pathway Map

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	STAT3 signaling	↓ (primary; tanshinone-driven)	↔	R/G	Reduced survival transcription	Cryptotanshinone widely reported STAT3 inhibitor; central anti-proliferative axis.
2	PI3K/AKT/mTOR	↓	↔ / ↑ metabolic protection	R/G	Suppressed anabolic signaling	Often linked to reduced proliferation and enhanced apoptosis.
3	ROS	↑ (dose-dependent; apoptosis)	↓ (phenolic antioxidant)	P/R	Redox divergence	Biphasic: pro-oxidant in tumors (tanshinones); antioxidant in normal tissues (salvianolic acids).
4	Intrinsic apoptosis (Bax↑, Bcl-2↓, caspases)	↑	↔	R/G	Mitochondrial apoptosis	Common downstream outcome of STAT3/AKT suppression and ROS elevation.
5	NF-κB	↓	↓	R/G	Anti-inflammatory / anti-survival	Contributes to both anti-cancer and cardiovascular protective roles.
6	Cell Cycle (Cyclin D1/CDK4, p21)	↓ proliferation	↔	G	G0/G1 or G2/M arrest	Model-dependent checkpoint enforcement.
7	HIF-1α / VEGF	↓	↔	G	Reduced angiogenesis	Reported anti-angiogenic effect; linked to tumor growth inhibition in vivo models.
8	NRF2	↔ / ↑ (context-dependent)	↑	R/G	Stress-response activation	Phenolic components may activate antioxidant pathways in normal tissues; cancer context variable.
9	Ca²⁺ / ER stress	↑ (stress-induced; model-dependent)	↔	P/R	ER-mitochondrial coupling	Observed in apoptosis models; not always primary mechanism.
10	Ferroptosis	↑ (investigational; ROS-linked)	↔	R/G	Lipid peroxidation stress	Possible secondary overlap via redox modulation; not universally established.
11	Clinical Translation Constraint	↓ (constraint)	↓ (constraint)	—	Bioavailability + heterogeneity	Variable extract composition (tanshinone vs phenolic content); limited oncology clinical trials.

TSF legend:
P: 0–30 min (direct redox or signaling interactions)
R: 30 min–3 hr (acute stress and transcriptional modulation)
G: >3 hr (gene regulation and phenotype outcomes)

TumCI, Tumor Cell invasion: Click to Expand ⟱

Source:

Type:

Tumor cell invasion is a critical process in cancer progression and metastasis, where cancer cells spread from the primary tumor to surrounding tissues and distant organs. This process involves several key steps and mechanisms:

1.Epithelial-Mesenchymal Transition (EMT): Many tumors originate from epithelial cells, which are typically organized in layers. During EMT, these cells lose their epithelial characteristics (such as cell-cell adhesion) and gain mesenchymal traits (such as increased motility). This transition is crucial for invasion.

2.Degradation of Extracellular Matrix (ECM): Tumor cells secrete enzymes, such as matrix metalloproteinases (MMPs), that degrade the ECM, allowing cancer cells to invade surrounding tissues. This degradation facilitates the movement of cancer cells through the tissue.

3.Cell Migration: Once the ECM is degraded, cancer cells can migrate. They often use various mechanisms, including amoeboid movement and mesenchymal migration, to move through the tissue. This migration is influenced by various signaling pathways and the tumor microenvironment.

4.Angiogenesis: As tumors grow, they require a blood supply to provide nutrients and oxygen. Tumor cells can stimulate the formation of new blood vessels (angiogenesis) through the release of growth factors like vascular endothelial growth factor (VEGF). This not only supports tumor growth but also provides a route for cancer cells to enter the bloodstream.

5.Invasion into Blood Vessels (Intravasation): Cancer cells can invade nearby blood vessels, allowing them to enter the circulatory system. This step is crucial for metastasis, as it enables cancer cells to travel to distant sites in the body.

6.Survival in Circulation: Once in the bloodstream, cancer cells must survive the immune response and the shear stress of blood flow. They can form clusters with platelets or other cells to evade detection.

7.Extravasation and Colonization: After traveling through the bloodstream, cancer cells can exit the circulation (extravasation) and invade new tissues. They may then establish secondary tumors (metastases) in distant organs.

8.Tumor Microenvironment: The surrounding microenvironment plays a significant role in tumor invasion. Factors such as immune cells, fibroblasts, and signaling molecules can either promote or inhibit invasion and metastasis.

Scientific Papers found: Click to Expand⟱

1191-

SM,

Salvia miltiorrhiza extract inhibits TPA‑induced MMP‑9 expression and invasion through the MAPK/AP‑1 signaling pathw

in-vitro,

BC,

MCF-7

Inflam↓, MMP9↓, TumCI↓, AP-1↓, lipidLev↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Core Metabolism/Glycolysis ⓘ

lipidLev↓, 1,

Migration ⓘ

AP-1↓, 1, MMP9↓, 1, TumCI↓, 1,

Immune & Inflammatory Signaling ⓘ

Inflam↓, 1,
Total Targets: 5

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: TumCI, Tumor Cell invasion

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:146  Target#:324  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid